Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | PDE2A | O00408 | 7/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | IGF1R | P08069 | 1/20 | 0.35 |
| ▸ | ABL1 | P00519 | 2/20 | 0.34 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.34 |
| ▸ | BRAF | P15056 | 1/20 | 0.34 |
| ▸ | KCNQ3 | O43525 | 1/20 | 0.34 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | CBLB | Q13191 | 1/20 | 0.34 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.34 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6176554 | 0.91 | BRAF (0.42) | MAPK1PDE2ACYP3A4GAACYP2C9 | |
| SCHEMBL6176257 | 0.90 | MAPT (0.41) | MAPK1PDE2ACYP3A4GAACYP2C9 | |
| SCHEMBL6176861 | 0.89 | PDE2A (0.39) | MAPK1PDE2ACYP3A4GAACYP2C9 | |
| SCHEMBL6175414 | 0.88 | MAPK1 (0.36) | MAPK1PDE2ACYP3A4GAACYP2C9 | |
| SCHEMBL6174504 | 0.87 | IGF1R (0.48) | PDE2AIGF1R | |
| SCHEMBL6172274 | 0.87 | CYP3A4 (0.40) | MAPK1PDE2ACYP3A4GAACYP2C9 | |
| SCHEMBL6171179 | 0.87 | POLB (0.37) | MAPK1PDE2ACYP3A4GAACYP2C9 | |
| SCHEMBL6173825 | 0.86 | MAPK1 (0.42) | MAPK1IGF1RBRAF | |
| SCHEMBL6171136 | 0.86 | CYP3A4 (0.47) | PDE2ACYP3A4GAACYP2C9CYP2C19 | |
| SCHEMBL6175553 | 0.86 | NPC1 (0.40) | MAPK1PDE2ACYP3A4GAACYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1599464-A2 | NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS | Aventis Pharma S.A. (FR) | 2005-11-30 | — | — | EP | disclosed |
| WO-2004070050-A2 | CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS | AVENTIS PHARMA S.A. (FR) | 2004-08-19 | — | — | WO | disclosed |